Search research articles
Contact Us
Filters
Showing results (331-340 of 358) with videos related to
Page
of 36
Sort By:
ACS Pharmacology & Translational Science
|
July 18, 2024
Development of Epigenetic Modifiers with Therapeutic Potential in FMS-Related Tyrosine Kinase 3/Internal Tandem Duplication (FLT3/ITD) Acute Myeloid Leukemia and Other Blood Malignancies
Gabriele Carullo, Sara Rossi, Valentina Giudice, et al.
European Journal of Medicinal Chemistry
|
July 25, 2024
Disulfide bond replacement with non-reducible side chain to tail macrolactamization for the development of potent and selective CXCR4 peptide antagonists endowed with flanking binding sites
Anna Maria Trotta, Stefano Tomassi, Gaetana Di Maiolo, et al.
International Journal of Cancer
|
July 1, 2023
Panitumumab plus trifluridine/tipiracil as anti-EGFR rechallenge therapy in patients with refractory RAS wild-type metastatic colorectal cancer: Overall survival and subgroup analysis of the randomized phase II VELO trial
Stefania Napolitano, Davide Ciardiello, Vincenzo De Falco, et al.
Cellular and Molecular Life Sciences : CMLS
|
July 13, 2022
SIRT1 pharmacological activation rescues vascular dysfunction and prevents thrombosis in MTHFR deficiency
Albino Carrizzo, Concetta Iside, Angela Nebbioso, et al.
Bioorganic Chemistry
|
October 18, 2025
New Vanillyl-capped HDAC inhibitors exhibit anti-tumor efficacy in neuroblastoma and glioblastoma cells
Ilaria Cursaro, Luca Frattaruolo, Laura Scalvini, et al.
The International Journal of Biochemistry & Cell Biology
|
July 16, 2024
Corrigendum to "Feijoa sellowiana derived natural Flavone exerts anti-cancer action displaying HDAC inhibitory activities" [Int. J. Biochem. Cell Biol. 39(10) (2007) 1902-1914]
Paola Bontempo, Luigi Mita, Marco Miceli, et al.
JAMA Oncology
|
May 18, 2023
Panitumumab Plus Trifluridine-Tipiracil as Anti-Epidermal Growth Factor Receptor Rechallenge Therapy for Refractory RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial
Stefania Napolitano, Vincenzo De Falco, Giulia Martini, et al.
The International Journal of Biochemistry & Cell Biology
|
July 3, 2007
Feijoa sellowiana derived natural Flavone exerts anti-cancer action displaying HDAC inhibitory activities
Paola Bontempo, Luigi Mita, Marco Miceli, et al.
Wiley Interdisciplinary Reviews. Systems Biology and Medicine
|
April 21, 2020
Molecular networks in Network Medicine: Development and applications
Edwin K Silverman, Harald H H W Schmidt, Eleni Anastasiadou, et al.
ESMO Open
|
April 3, 2020
Feasibility of next-generation sequencing in clinical practice: results of a pilot study in the Department of Precision Medicine at the University of Campania 'Luigi Vanvitelli'
Vincenzo De Falco, Luca Poliero, Pietro Paolo Vitello, et al.
Page
of 36
Search research articles
Search
Showing results (331-340 of 358) with videos related to
Sort By:
Page
of 36
ACS Pharmacology & Translational Science
|
July 18, 2024
Development of Epigenetic Modifiers with Therapeutic Potential in FMS-Related Tyrosine Kinase 3/Internal Tandem Duplication (FLT3/ITD) Acute Myeloid Leukemia and Other Blood Malignancies
Gabriele Carullo, Sara Rossi, Valentina Giudice, et al.
European Journal of Medicinal Chemistry
|
July 25, 2024
Disulfide bond replacement with non-reducible side chain to tail macrolactamization for the development of potent and selective CXCR4 peptide antagonists endowed with flanking binding sites
Anna Maria Trotta, Stefano Tomassi, Gaetana Di Maiolo, et al.
International Journal of Cancer
|
July 1, 2023
Panitumumab plus trifluridine/tipiracil as anti-EGFR rechallenge therapy in patients with refractory RAS wild-type metastatic colorectal cancer: Overall survival and subgroup analysis of the randomized phase II VELO trial
Stefania Napolitano, Davide Ciardiello, Vincenzo De Falco, et al.
Cellular and Molecular Life Sciences : CMLS
|
July 13, 2022
SIRT1 pharmacological activation rescues vascular dysfunction and prevents thrombosis in MTHFR deficiency
Albino Carrizzo, Concetta Iside, Angela Nebbioso, et al.
Bioorganic Chemistry
|
October 18, 2025
New Vanillyl-capped HDAC inhibitors exhibit anti-tumor efficacy in neuroblastoma and glioblastoma cells
Ilaria Cursaro, Luca Frattaruolo, Laura Scalvini, et al.
The International Journal of Biochemistry & Cell Biology
|
July 16, 2024
Corrigendum to "Feijoa sellowiana derived natural Flavone exerts anti-cancer action displaying HDAC inhibitory activities" [Int. J. Biochem. Cell Biol. 39(10) (2007) 1902-1914]
Paola Bontempo, Luigi Mita, Marco Miceli, et al.
JAMA Oncology
|
May 18, 2023
Panitumumab Plus Trifluridine-Tipiracil as Anti-Epidermal Growth Factor Receptor Rechallenge Therapy for Refractory RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial
Stefania Napolitano, Vincenzo De Falco, Giulia Martini, et al.
The International Journal of Biochemistry & Cell Biology
|
July 3, 2007
Feijoa sellowiana derived natural Flavone exerts anti-cancer action displaying HDAC inhibitory activities
Paola Bontempo, Luigi Mita, Marco Miceli, et al.
Wiley Interdisciplinary Reviews. Systems Biology and Medicine
|
April 21, 2020
Molecular networks in Network Medicine: Development and applications
Edwin K Silverman, Harald H H W Schmidt, Eleni Anastasiadou, et al.
ESMO Open
|
April 3, 2020
Feasibility of next-generation sequencing in clinical practice: results of a pilot study in the Department of Precision Medicine at the University of Campania 'Luigi Vanvitelli'
Vincenzo De Falco, Luca Poliero, Pietro Paolo Vitello, et al.
Page
of 36